Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma

Nivolumab is an antibody that prevent cancer cells from suppressing the immune response so that the body can attack and kill the cancer

Montanide® is an activator of immunity that enhances response to vaccination through slow release of the peptides from the injection site and its ability to create an inflammation and stimulate the recruitment of specific cells of your immune system. Montanide® will be mixed with the personalized neoantigen vaccine

Ipilimumab is an antibody that prevent cancer cells from suppressing the immune response so that the body can attack and kill the cancer